Tel:
Fax:
Email:
Creative Biolabs

NeuroMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P618)

[CAT#: NRP-0422-P618]

A functional antibody raised against Human Alpha Synuclein.

Host Species:
Human
Species Reactivity:
Human
Applications:
WB; ELISA; IHC; In Vitro; In Vivo

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

Size:
Conjugation:
Endotoxin:
Purity:
Function:
inquiry
Product Overview

Description

NI-202.12F4 binds to α-synuclein fragments comprising aa 1-60 but not to N-terminally truncated fragments comprising amino acids 61-140 or 96-140. WB analysis shows that NI-202.12F4 selectively binds to α-synuclein. NI-202.12F4 selectively binds to very N-terminus of α-synuclein.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Human

Applications

WB; ELISA; IHC; In Vitro; In Vivo
Product Properties

Formulation

PBS only

Preservatives

BSA Free

Concentration

1mg/mL

Purification

Purified recombinant IgG prepared by affinity chromatography on Protein A from a mammalian cell line

Purity

>95% by SDS PAGE or HPLC

Endotoxin Level

Regular Endotoxin < 5 EU/mg
Low Endotoxin < 1 EU/mg

Shipping

Gel Packs

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Research Use Only

For research use only
Target

Target

Alpha Synuclein

Official Name

SNCA

Full Name

Alpha-synuclein

Alternative Names

SNCA; NACP; PARK1; PARK4; PD1; synuclein alpha

Gene ID

6622 (Human); 20617 (Mouse)

Uniprot ID

Product Pictures
ELISA

Figure 1 Recombinant human α-synuclein antibodies against different epitopes.

Recombinant full-length and truncated α-synuclein were coated onto ELISA plates at the same coating concentration (20 μg/ml).

ELISA

Figure 2 Recombinant human α-synuclein antibody binds α-synuclein but not β- and γ-synuclein in a direct ELISA.

Recombinant α-, β- and γ-synuclein coated onto ELISA plates at the same coating concentration (2 μg/ml) together with recombinant human α-synuclein antibody or pan-synuclein antibody Incubation.

WB

Figure 3 Recombinant human α-synuclein antibody NI-202.12F4 binds α-synuclein but not β- and γ-synuclein in Western blot analysis.

Recombinant α-, β- and γ-synuclein (750 ng each) were subjected to SDS-PAGE followed by Western blot analysis.

ELISA

Figure 4. Recombinant NI-202.12F4 shows high affinity binding to wild-type and pathogenic α-synuclein mutants.

Recombinant wild type (●), A53T (▪), A30P (*) and E64K (⋄Human α-synuclein was coated on ELISA plates (2 μg/ml) and probed with different concentrations of NI202.12F4.

FuncS

Figure 5 Chronic treatment with NI-202.12F4 improved the locomotor capacity of α-synuclein A53T transgenic mice.

The time required to turn down was significantly reduced in NI-202.12F4-treated animals (t-turn; 1.7±0.3 vs. 4.6±0.6 s, p=0.0002, two-tailed Student's t-test).

FuncS

Figure 6 Chronic treatment of α-synuclein A53T transgenic mice with NI-202.12F4 results in increased plasma levels of human A53T α-synuclein.

Plasma samples were prepared from 12.5-month-old α-synuclein A53T transgenic mice treated with weekly intraperitoneal injections of 5 mg/kg NI-202.12F4 or PBS for 2 months. Blood was collected 24 hours after the last application.

Related Products
Neural Cell Lines
Neural Antibodies
Neural Genes
Kits
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Send inquiry